Description:
The GEM Hemochron 100 System is a state-of-the-art medical device developed by Accriva Diagnostics Inc. It includes the GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+), the GEM Hemochron 100 Low Range Activated Clotting Time Test (ACT-LR), and directCHECK Whole Blood Control units at Levels 1 and 2 for both ACT+ and ACT-LR.
Its primary usage lies within the realm of coagulation testing - a critical aspect of healthcare that measures how efficiently the blood forms clots to prevent excessive bleeding. This device has shown to be exceptionally beneficial in routine monitoring for anticoagulant therapies, or during sensitive surgical procedures where immediate results are required for effective decision making. It offers both ACT+ and ACT-LR tests, allowing medical professionals a valuable range to select from based on their specific requirements.
Further enhancing its usefulness, the system comes with directCHECK Whole Blood Control units. These tools provide reliable assurance, allowing professionals to confirm test accuracy and precision. This feature enables the system's consistent usage, upholding the highest standards of patient safety and care.
Accriva Diagnostics Inc. developed the GEM Hemochron 100 System with a keen understanding of the vital role rapid, accurate clotting time results play in clinical decision-making processes. It is carefully designed to aid physicians and healthcare professionals in providing optimal patient care, improving outcomes in a range of situations from routine anticoagulant management to critical and emergency scenarios.
... Read moreDescription:
The HemosIL ReadiPlasTin is an effective solution designed to enhance diagnostic procedures in haematology and coagulation testing. With an emphasis on patient care, this device significantly contributes to reducing diagnosis time, ensuring a more efficient healthcare procedure.
The HemosIL ReadiPlasTin primarily serves as a Prothrombin Time (PT) test. It evaluates how long it takes for blood to clot, thus providing invaluable information relating to conditions such as haemophilia, deep vein thrombosis, and liver disease.
Key Benefits
The HemosIL ReadiPlasTin offers numerous benefits that make it a standout choice within the medical diagnostic industry.
Instrumentation Laboratory Co. is committed to improving patient care through high-quality, reliable devices. The HemosIL ReadiPlasTin is a reflection of this commitment, offering a strong solution in the realm of diagnostic testing.